The first human trial of a nasal vaccine to prevent Alzheimer’s disease is expected to begin at a Boston hospital. The vaccine is entering phase 1 of clinical trials and is the result of 20 years of research.
Alzheimer’s disease is the most common form of dementia. Dementia is a general term for the cognitive decline seen in older people. Statistics indicate that a person is diagnosed with dementia every 3 seconds worldwide with over 10 million new cases each year.
Alzheimer’s disease is a progressive disease that destroys memory and other important mental functions. The main symptoms are memory loss and confusion.
The vaccine is a 2-dose nasal spray that will be given 1 week apart. He will use a chemical called Protollin to boost the immune system and activate white blood cells.
Watch the video to learn more.